Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ-B ligand-stimulated signalling pathways

Yutaka Fukuma, Eiko Sakai, Shunsuke Komaki, Kazuhisa Nishishita, Kuniaki Okamoto, Takayuki Tsukuba

Research output: Contribution to journalLetter

1 Citation (Scopus)

Abstract

Rutaecarpine is a major alkaloid isolated from Evodia rutaecarpa. Here, we investigated the effects of rutaecarpine on osteoclast differentiation induced by macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor κ-B ligand (RANKL) in bone marrow-derived macrophages (BMMs). Treatment with rutaecarpine significantly inhibited osteoclastogenesis and prevented bone resorption of BMM-derived osteoclasts. Mechanistically, rutaecarpine decreased the protein level of nuclear factor of activated T cells cytoplasmic-1 (NFATc1) and the phosphorylation of other signalling pathways during the osteoclast differentiation. Thus, rutaecarpine may be useful as a therapeutic agent for the treatment of bone diseases.

Original languageEnglish
Pages (from-to)863-865
Number of pages3
JournalClinical and Experimental Pharmacology and Physiology
Volume45
Issue number8
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Macrophage Colony-Stimulating Factor Receptors
Osteogenesis
Ligands
Osteoclasts
Evodia
Macrophages
NFATC Transcription Factors
Bone Diseases
Bone Resorption
Alkaloids
Phosphorylation
rutecarpine
Bone and Bones

Keywords

  • bone marrow-derived macrophages
  • osteoclast differentiation
  • rutaecarpine

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ-B ligand-stimulated signalling pathways. / Fukuma, Yutaka; Sakai, Eiko; Komaki, Shunsuke; Nishishita, Kazuhisa; Okamoto, Kuniaki; Tsukuba, Takayuki.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 45, No. 8, 01.08.2018, p. 863-865.

Research output: Contribution to journalLetter

@article{e05717cc6fb44bd8806e27957ba4ccb7,
title = "Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ-B ligand-stimulated signalling pathways",
abstract = "Rutaecarpine is a major alkaloid isolated from Evodia rutaecarpa. Here, we investigated the effects of rutaecarpine on osteoclast differentiation induced by macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor κ-B ligand (RANKL) in bone marrow-derived macrophages (BMMs). Treatment with rutaecarpine significantly inhibited osteoclastogenesis and prevented bone resorption of BMM-derived osteoclasts. Mechanistically, rutaecarpine decreased the protein level of nuclear factor of activated T cells cytoplasmic-1 (NFATc1) and the phosphorylation of other signalling pathways during the osteoclast differentiation. Thus, rutaecarpine may be useful as a therapeutic agent for the treatment of bone diseases.",
keywords = "bone marrow-derived macrophages, osteoclast differentiation, rutaecarpine",
author = "Yutaka Fukuma and Eiko Sakai and Shunsuke Komaki and Kazuhisa Nishishita and Kuniaki Okamoto and Takayuki Tsukuba",
year = "2018",
month = "8",
day = "1",
doi = "10.1111/1440-1681.12941",
language = "English",
volume = "45",
pages = "863--865",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ-B ligand-stimulated signalling pathways

AU - Fukuma, Yutaka

AU - Sakai, Eiko

AU - Komaki, Shunsuke

AU - Nishishita, Kazuhisa

AU - Okamoto, Kuniaki

AU - Tsukuba, Takayuki

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Rutaecarpine is a major alkaloid isolated from Evodia rutaecarpa. Here, we investigated the effects of rutaecarpine on osteoclast differentiation induced by macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor κ-B ligand (RANKL) in bone marrow-derived macrophages (BMMs). Treatment with rutaecarpine significantly inhibited osteoclastogenesis and prevented bone resorption of BMM-derived osteoclasts. Mechanistically, rutaecarpine decreased the protein level of nuclear factor of activated T cells cytoplasmic-1 (NFATc1) and the phosphorylation of other signalling pathways during the osteoclast differentiation. Thus, rutaecarpine may be useful as a therapeutic agent for the treatment of bone diseases.

AB - Rutaecarpine is a major alkaloid isolated from Evodia rutaecarpa. Here, we investigated the effects of rutaecarpine on osteoclast differentiation induced by macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor κ-B ligand (RANKL) in bone marrow-derived macrophages (BMMs). Treatment with rutaecarpine significantly inhibited osteoclastogenesis and prevented bone resorption of BMM-derived osteoclasts. Mechanistically, rutaecarpine decreased the protein level of nuclear factor of activated T cells cytoplasmic-1 (NFATc1) and the phosphorylation of other signalling pathways during the osteoclast differentiation. Thus, rutaecarpine may be useful as a therapeutic agent for the treatment of bone diseases.

KW - bone marrow-derived macrophages

KW - osteoclast differentiation

KW - rutaecarpine

UR - http://www.scopus.com/inward/record.url?scp=85050491993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050491993&partnerID=8YFLogxK

U2 - 10.1111/1440-1681.12941

DO - 10.1111/1440-1681.12941

M3 - Letter

C2 - 29582460

AN - SCOPUS:85050491993

VL - 45

SP - 863

EP - 865

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 8

ER -